J F Farley

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi Medication adherence changes following value-based insurance design
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599 7360, USA
    Am J Manag Care 18:265-74. 2012
  2. ncbi Continuity of antipsychotic medication management for Medicaid patients with schizophrenia
    Joel F Farley
    UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Campus Box 7573, Kerr Hall 2204, Chapel Hill, NC 27599, USA
    Psychiatr Serv 62:747-52. 2011
  3. ncbi The status of PhD education in economic, social, and administrative sciences between 2005 and 2008
    Joel F Farley
    Eshelman School of Pharmacy, University of North Carolina, Campus Box 7573, 2204 Kerr Hall, Chapel Hill, NC 27599, USA
    Am J Pharm Educ 74:126. 2010
  4. ncbi Medicaid prescription drug utilization and expenditures following Part D
    Joel F Farley
    University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, Chapel Hill, NC 27599, USA
    J Health Care Poor Underserved 21:715-28. 2010
  5. ncbi Medicaid prescription cost containment and schizophrenia: a retrospective examination
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Med Care 48:440-7. 2010
  6. ncbi Professional implications of the expansion of pharmacy-based medical clinics
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, USA
    J Am Pharm Assoc (2003) 47:410-4. 2007
  7. ncbi Trends and determinants of prescription medication use for treatment of osteoporosis
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
    Am J Health Syst Pharm 66:1191-201. 2009
  8. ncbi Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Clin Ther 30:1524-39; discussion 1506-7. 2008
  9. ncbi Effect of the women's health initiative on prescription anti-osteoporosis medication utilization
    J F Farley
    Division of Pharmaceutical Outcomes and Policy, University of North Carolina School of Pharmacy, CB 7360, 2201 Kerr Hall, Chapel Hill, NC 27599 7360, USA
    Osteoporos Int 19:1603-12. 2008
  10. ncbi Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions
    Spencer D Dorn
    Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Gastroenterology 137:518-24, 524.e1-2. 2009

Detail Information

Publications13

  1. ncbi Medication adherence changes following value-based insurance design
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599 7360, USA
    Am J Manag Care 18:265-74. 2012
    ....
  2. ncbi Continuity of antipsychotic medication management for Medicaid patients with schizophrenia
    Joel F Farley
    UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Campus Box 7573, Kerr Hall 2204, Chapel Hill, NC 27599, USA
    Psychiatr Serv 62:747-52. 2011
    ..The purpose of this study was to examine whether medication refill behavior varies by the number of prescribers of antipsychotic medication a patient has...
  3. ncbi The status of PhD education in economic, social, and administrative sciences between 2005 and 2008
    Joel F Farley
    Eshelman School of Pharmacy, University of North Carolina, Campus Box 7573, 2204 Kerr Hall, Chapel Hill, NC 27599, USA
    Am J Pharm Educ 74:126. 2010
    ..To describe the funding, education, enrollment, and graduation patterns from economic, social, and administrative sciences PhD programs in colleges and schools of pharmacy in the United States...
  4. ncbi Medicaid prescription drug utilization and expenditures following Part D
    Joel F Farley
    University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, Chapel Hill, NC 27599, USA
    J Health Care Poor Underserved 21:715-28. 2010
    ..Our results provide a glimpse of the impact of Part D on long-term growth in the Medicaid prescription drug benefit...
  5. ncbi Medicaid prescription cost containment and schizophrenia: a retrospective examination
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Med Care 48:440-7. 2010
    ..The objectives of this study were to examine the influence of these policies on (1) compliance to antipsychotic medications and (2) mental health care utilization and payments among patients with schizophrenia...
  6. ncbi Professional implications of the expansion of pharmacy-based medical clinics
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, USA
    J Am Pharm Assoc (2003) 47:410-4. 2007
    ..To describe challenges and opportunities to the profession of pharmacy associated with the emergence of pharmacy-based medical clinics...
  7. ncbi Trends and determinants of prescription medication use for treatment of osteoporosis
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
    Am J Health Syst Pharm 66:1191-201. 2009
    ..Trends in the use of different treatments for osteoporosis among the civilian, ambulatory U.S. population are described...
  8. ncbi Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications
    Joel F Farley
    Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Clin Ther 30:1524-39; discussion 1506-7. 2008
    ..Antipsychotic medications account for more prescription expenditures in Medicaid than any other therapeutic category. This has made them an attractive target for states hoping to curtail rising expenditures...
  9. ncbi Effect of the women's health initiative on prescription anti-osteoporosis medication utilization
    J F Farley
    Division of Pharmaceutical Outcomes and Policy, University of North Carolina School of Pharmacy, CB 7360, 2201 Kerr Hall, Chapel Hill, NC 27599 7360, USA
    Osteoporos Int 19:1603-12. 2008
    ..Overall, the prevalence of prescription anti-osteoporosis medication use declined following the WHI. This has important implications for osteoporosis prevention and treatment...
  10. ncbi Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions
    Spencer D Dorn
    Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Gastroenterology 137:518-24, 524.e1-2. 2009
    ..We sought to determine the relationship between promotion of tegaserod and the number of office visits for abdominal pain, constipation, and bloating; diagnoses of irritable bowel syndrome (IBS); and tegaserod prescriptions...
  11. ncbi A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005
    Richard A Hansen
    University of North Carolina, Chapel Hill, 27599, USA
    Clin Ther 32:1308-19. 2010
    ....
  12. ncbi Economic grand rounds: did Medicare Part D improve access to medications?
    Marisa Elena Domino
    Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 1104G McGavran Greenberg Hall, CB 7411, Chapel Hill, NC 27599 7411, USA
    Psychiatr Serv 61:118-20. 2010
    ..There was no strong evidence that Part D was associated with large changes in access to medications in the four classes of medications examined here...
  13. ncbi APhA2007 House of Delegates: improving practice today, preparing for and protecting the profession's future
    Kristin Weitzel
    Green Cove Springs, FL, USA
    J Am Pharm Assoc (2003) 47:548, 550-2, 559-60, passim. 2007